Cargando…

Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease

BACKGROUND: Progressive overloads of intrahepatic triglycerides are related to metabolic dysregulation of multiple lipid and lipoprotein profiles, but whether similar dose effects are found in each subtype of metabolic associated fatty liver disease (MAFLD) remains unclear. We aimed to characterize...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Tingfeng, Ye, Junzhao, Shao, Congxiang, Li, Fuxi, Lin, Yansong, Ma, Qianqian, Wang, Wei, Feng, Shiting, Zhong, Bihui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662313/ https://www.ncbi.nlm.nih.gov/pubmed/34899591 http://dx.doi.org/10.3389/fendo.2021.691556

Ejemplares similares

Effect of orlistat on liver fat content in patients with nonalcoholic fatty liver disease with obesity: assessment using magnetic resonance imaging-derived proton density fat fraction
por: Ye, Junzhao, et al.
Publicado: (2019)

The Ability of Lipoprotein (a) Level to Predict Early Carotid Atherosclerosis Is Impaired in Patients With Advanced Liver Fibrosis Related to Metabolic-Associated Fatty Liver Disease
por: Wu, Tingfeng, et al.
Publicado: (2022)

Distinct Dose-Dependent Association of Free Fatty Acids with Diabetes Development in Nonalcoholic Fatty Liver Disease Patients
por: Li, Fuxi, et al.
Publicado: (2021)

Insulin resistance exhibits varied metabolic abnormalities in nonalcoholic fatty liver disease, chronic hepatitis B and the combination of the two: a cross-sectional study
por: Ye, Junzhao, et al.
Publicado: (2019)

Lipid-Lowering Responses to Dyslipidemia Determine the Efficacy on Liver Enzymes in Metabolic Dysfunction-Associated Fatty Liver Disease with Hepatic Injuries: A Prospective Cohort Study
por: Liao, Xianhua, et al.
Publicado: (2022)

Metabolic benefits of changing sedentary lifestyles in nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials
por: Ma, Qianqian, et al.
Publicado: (2022)

Distinct Cause of Death Profiles of Hospitalized Non-alcoholic Fatty Liver Disease: A 10 Years' Cross-Sectional Multicenter Study in China
por: Lin, Yansong, et al.
Publicado: (2021)

Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis
por: Li, Fuxi, et al.
Publicado: (2021)

Normalization of γ-glutamyl transferase levels is associated with better metabolic control in individuals with nonalcoholic fatty liver disease
por: Ma, Qianqian, et al.
Publicado: (2021)

Discrepancies between Nonalcoholic and Metabolic-associated Fatty Liver Disease by Multiple Steatosis Assessment
por: Shao, Congxiang, et al.
Publicado: (2022)

Vitamin D Status Presents Different Relationships with Severity in Metabolic-Associated Fatty Liver Disease Patients with or without Hepatitis B Infection
por: Luo, Ling, et al.
Publicado: (2022)

Steatosis grading consistency between controlled attenuation parameter and MRI-PDFF in monitoring metabolic associated fatty liver disease
por: Shao, Cong xiang, et al.
Publicado: (2021)

Metabolomics to identify fingerprints of carotid atherosclerosis in nonobese metabolic dysfunction-associated fatty liver disease
por: Shao, Congxiang, et al.
Publicado: (2023)

Impact of skeletal muscle mass evaluating methods on severity of metabolic associated fatty liver disease in non-elderly adults
por: Zhou, Ting, et al.
Publicado: (2023)

The Additive Values of the Classification of Higher Serum Uric Acid Levels as a Diagnostic Criteria for Metabolic-Associated Fatty Liver Disease
por: He, Jie, et al.
Publicado: (2022)

Effects of sitagliptin on intrahepatic lipid content in patients with non-alcoholic fatty liver disease
por: Wang, Xingchun, et al.
Publicado: (2022)

Age patterns of nonalcoholic fatty liver disease incidence: heterogeneous associations with metabolic changes
por: Lin, Yansong, et al.
Publicado: (2022)

Lipoprotein Insulin Resistance Index Reflects Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease
por: Vittal, Anusha, et al.
Publicado: (2020)

Prevalence and Significance of Antinuclear Antibodies in Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Luo, Ling, et al.
Publicado: (2022)

Correlation of multiple lipid and lipoprotein ratios with nonalcoholic fatty liver disease in patients with newly diagnosed type 2 diabetic mellitus: A retrospective study
por: Li, Ran, et al.
Publicado: (2023)

Triglyceride to high-density lipoprotein cholesterol ratio is an independent predictor of liver fibrosis among pediatrics non-alcoholic fatty liver disease
por: Ting, Yi-Wen, et al.
Publicado: (2022)

Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids
por: Orešič, Matej, et al.
Publicado: (2013)

Glucose metabolism status modifies the relationship between lipoprotein(a) and carotid plaques in individuals with fatty liver disease
por: Wang, Jiaxuan, et al.
Publicado: (2022)

Triglyceride-Rich Lipoproteins and Glycoprotein A and B Assessed by 1H-NMR in Metabolic-Associated Fatty Liver Disease
por: Moreno-Vedia, Juan, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation
por: Fon Tacer, Klementina, et al.
Publicado: (2011)

Dynamic monitoring with shear wave elastography predicts outcomes of chronic hepatitis B patients with decompensated cirrhosis
por: Ye, Junzhao, et al.
Publicado: (2021)

Understanding gut-liver axis nitrogen metabolism in Fatty Liver Disease
por: Delgado, Teresa C., et al.
Publicado: (2022)

The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease
por: Qiu, Jiajun, et al.
Publicado: (2023)

The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease
por: Perla, Francesco M., et al.
Publicado: (2017)

Editorial: Obesity, Smoking, and Fatty Liver Disease
por: Sinha-Hikim, Amiya P., et al.
Publicado: (2018)

Alternative RNA Splicing in Fatty Liver Disease
por: Wu, Panyisha, et al.
Publicado: (2021)

Endotoxins and Non-Alcoholic Fatty Liver Disease
por: Kessoku, Takaomi, et al.
Publicado: (2021)

Lean nonalcoholic fatty liver disease and sarcopenia
por: Chen, Milian, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population
por: Ciardullo, Stefano, et al.
Publicado: (2021)

THE RELATION BETWEEN THE FAT CONTENT OF THE BILE AND FATTY CHANGES IN THE LIVER
por: Le Count, Edwin R., et al.
Publicado: (1914)

Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD)
por: Cuthbertson, Daniel J., et al.
Publicado: (2021)

Quantification of lumbar vertebral fat deposition: Correlation with menopausal status, non-alcoholic fatty liver disease and subcutaneous adipose tissue
por: Zheng, Chu-Shan, et al.
Publicado: (2023)

Integrated analysis of potential gene crosstalk between non-alcoholic fatty liver disease and diabetic nephropathy
por: Yan, Qianqian, et al.
Publicado: (2022)

The Effect of Empagliflozin on Liver Fat in Type 2 Diabetes Mellitus Patients With Non-Alcoholic Fatty Liver Disease
por: Pokharel, Arbinda, et al.
Publicado: (2021)

IRX3 plays an important role in the pathogenesis of metabolic-associated fatty liver disease by regulating hepatic lipid metabolism
por: Ma, Yongqiang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uughin3fkodfvu97vpe0grm00s